12 trials tracked for Dehydration: 4 in phase 3 or 4 and 1 with published results. The most-cited published study has 35 citations.
Showing the 12 most-cited and recently-updated of 12 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
Clinical evidence regarding the management of dehydration includes the use of recombinant human hyaluronidase and Hylenex [1, 2]. In studies evaluating recombinant human hyaluronidase, mean total volumes of fluid administered at single infusion sites or across all infusion sites did not show statistically significant differences between groups (p=0.5064; p=0.5035) 1.
The administration of hyaluronidase combined with rehydration fluid was associated with a post-treatment Gorelick Dehydration Score of 0.5 and -3.0 3. Additionally, the use of Hylenex-facilitated subcutaneous Lactated Ringer's infusion demonstrated consistent times for infusing 1000 mL of fluid across study groups (approximately 6.8 minutes) 4.
AI synthesis of 8 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.